EDGAR Filing Documents for 0001193125-14-240177

Form S-4 - Registration of securities, business combinations:

SEC Accession No. 0001193125-14-240177

Filing Date

2014-06-18

Accepted

2014-06-18 09:24:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-4	d742263ds4.htm	S-4	1453345
2	EX-5.1	d742263dex51.htm	EX-5.1	6887
3	EX-23.1	d742263dex231.htm	EX-23.1	1706
4	EX-23.2	d742263dex232.htm	EX-23.2	2507
5	EX-23.3	d742263dex233.htm	EX-23.3	1820
6	EX-23.4	d742263dex234.htm	EX-23.4	3474
7	EX-99.1	d742263dex991.htm	EX-99.1	101196
8	EX-99.2	d742263dex992.htm	EX-99.2	27395
9	EX-99.3	d742263dex993.htm	EX-99.3	9622
10	EX-99.4	d742263dex994.htm	EX-99.4	24675
11	GRAPHIC	g742263g09s22.jpg	GRAPHIC	18448
12	GRAPHIC	g742263g22p23.jpg	GRAPHIC	11236
13	GRAPHIC	g742263g27g47.jpg	GRAPHIC	9225
14	GRAPHIC	g742263g55e62.jpg	GRAPHIC	12182
15	GRAPHIC	g742263g81b62.jpg	GRAPHIC	3414
	Complete submission text file	0001193125-14-240177.txt		1709670

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8

Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)